Thursday, December 31, 2020 6:18:14 PM
Recent KYMR News
- Kymera Therapeutics to Participate in Upcoming September Investor Conferences • GlobeNewswire Inc. • 08/28/2024 11:00:00 AM
- Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 08/21/2024 03:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 09:24:59 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/20/2024 08:31:30 PM
- Kymera Therapeutics Announces Pricing of $225 Million Public Offering • GlobeNewswire Inc. • 08/20/2024 02:45:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/19/2024 08:01:40 PM
- Kymera Therapeutics Announces Proposed Public Offering • GlobeNewswire Inc. • 08/19/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 11:15:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:10:08 AM
- Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 • GlobeNewswire Inc. • 07/31/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 10:00:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:28:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/15/2024 08:31:05 PM
- Kymera Therapeutics to Present in Fireside Chat at the UBS Virtual Targeted Protein Degradation Day • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News • IH Market News • 07/09/2024 10:54:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:22:02 PM
- Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy • GlobeNewswire Inc. • 07/08/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:30:03 PM
- Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting • GlobeNewswire Inc. • 06/14/2024 11:00:00 AM
- Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting • GlobeNewswire Inc. • 06/01/2024 12:00:00 PM
- Kymera Therapeutics to Participate in Upcoming June Investor Conferences • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:00:00 PM
- Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting • GlobeNewswire Inc. • 05/22/2024 03:20:00 PM
- Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting • GlobeNewswire Inc. • 05/14/2024 02:00:00 PM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM